Every number has its term printed next to it
Maximus publishes three plan lengths for each compounded drug — one month, four months, twelve months — with the figure for each sitting beside the term it belongs to. There is no headline rate whose condition you have to hunt for.
That sounds small. It is not. Twenty-two of the forty-nine sellers on this roster have a recorded price-stability problem: a promotional first month, a tier requirement, a discount with no expiry, or two prices for one product. Maximus has none of those.
It also publishes a personalized-dose floor beneath each headline plan, so the cheapest figure the program can produce is visible rather than implied. The trade is real, though: the number that holds with no commitment is the one-month rate, and the cheaper figures require signing up for four months or a year.
The no-commitment rate is expensive
Compare like with like and Maximus is not cheap. Its one-month semaglutide rate is among the highest of the forty-nine sellers here for a month-to-month compounded plan, and the tirzepatide equivalent is higher still.
The twelve-month figures are competitive. They are also a year of your money committed in exchange for about two-fifths off the semaglutide rate and about a third off the tirzepatide one.
So the honest way to read Maximus is as two different products. If you know you are staying on treatment for a year and will actually take the annual plan, the price is fine. If you want to try a month, you are paying near the top of the market for the privilege of not committing.
No membership, stated twice and defined
The tirzepatide page carries no membership fees, transparent pricing in its own checklist. The Zepbound page prints no hidden fees and no membership directly beside the price. The site elsewhere describes its pricing as direct-pay covering doctor visits, medications and ongoing support.
Seventeen of the forty-nine sellers here charge no membership, so Maximus is not alone, but it is one of the clearer statements of it. Crucially, it also says what the price covers rather than only what it does not — visits, medication, support — which turns a negative claim into a scope statement.
For a reader comparing across boards, that matters more than the headline. A Maximus month is one charge. Sixteen of the forty-nine sellers here bill a separate membership on top of the drug, and their advertised figures are not the same kind of number.
Brand Zepbound at a posted price, pen and vial alike
Maximus sells brand-name Zepbound at a published self-pay figure, and charges the same for the multi-dose pen as for the vial. Twenty-nine of the forty-nine sellers here offer a brand route at all, and fewer post a figure for the pen presentation specifically.
The pen matters practically. It is ready to use, with no drawing up from a vial, and paying no premium for that convenience is a genuine point in Maximus's favor.
There is no compounded-to-brand comparison built into the page in the way a couple of sellers here manage, since the brand product lives on its own page. But both figures are public, and both carry the no-membership language.
Advisory doctors are not prescribing doctors
Maximus names several physicians, and they are real people with real credentials. Its own page calls them a clinical advisory team, and they are largely academics. The founder is a clinical psychologist.
None of them is presented as your prescriber or as a medical director. The prescribing question is answered generically — US-based, fully licensed, board-certified physicians — with no individual attached. That is why this record does not count Maximus among the thirty-one sellers here that name a prescriber.
The pharmacy is also unnamed. Maximus describes its vetting process instead: US-based, fully licensed compounding pharmacies operating to USP standards. Ten of the forty-nine sellers here name one.
Three states are excluded from the weight program outright, which Maximus states in a single plain sentence rather than making you assemble it from footnotes. That is better disclosure than most, and it is a hard no if you live in one of them.
Maximus's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $249.99/moVerbatim: "1 Month $249.99 /mo · 4-Month Plan MOST POPULAR $199.49 /mo · 12-Month Plan BEST VALUE $150.32 /mo". Each term is printed beside its own figure; $249.99 is the rate with no commitment. | September 2026source |
| Tirzepatide (compounded) | $359.99/moVerbatim: "1 Month $359.99 /mo · 4-Month Plan MOST POPULAR $298.99 /mo · 12-Month Plan BEST VALUE $240.66 /mo". The same page states "No membership fees, transparent pricing". | September 2026source |
| Tirzepatide (brand) | $449.99/mo"Starting at $449.99 /mo / No hidden fees / No membership / Free discreet shipping / FDA-approved / Board-certified doctors", beside the note "Now available in the multi-dose KwikPen® at the same self-pay price as the vial." | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 56 providers reviewed here are paid partners today; the other 52 are not. See how this works.
See Maximus's current price →Good fit if
- Readers who want the commitment length printed beside every figure so no rate can be misread as the month-to-month one.
- People staying on treatment for a year who will genuinely take the twelve-month plan the cheaper figures require.
- Buyers who want brand Zepbound at a posted cash price, including the ready-to-use pen at no premium over the vial.
- Anyone who wants one charge rather than a drug price with a membership stacked on top, stated on the product page and defined by what it covers.
Look elsewhere if
- Anyone buying month to month on price. The no-commitment semaglutide rate is among the highest of the forty-nine sellers here; Cora Health and Fifty 410 both publish lower no-commitment figures.
- Residents of the three states excluded from the weight program.
- Readers who want a named prescriber or medical director. The physicians Maximus names are an advisory board; Cora Health names its medical director and prescribing group.
- Buyers who need the compounding pharmacy named. Joi + Blokes names seven in its terms and Cora Health names two, against ten of the forty-nine that name any.
How this review was verified
- Read both compounded protocol pages and the Zepbound page at their source URLs and logged all three published plan lengths per drug plus the brand figure, with the date read.
- Recorded the one-month rate as the price row for each compounded drug, because that is the rate that holds with no commitment, and kept the four- and twelve-month figures in the qualifier with their terms attached.
- Logged the no-membership language verbatim from two separate product pages plus the direct-pay scope statement, rather than inferring the absence of a fee.
- Confirmed that the brand pen and vial carry the same self-pay figure, quoted from the note on the Zepbound page.
- Read the state answer on the weight-loss page and recorded the three named exclusions from Maximus's own sentence.
- Checked how the named physicians are described on Maximus's own page, found them presented as a clinical advisory team rather than as prescribers, and recorded the prescriber as unnamed on that basis.
- Checked the pharmacy question and recorded that Maximus describes a vetting process rather than naming a partner.